Formed in 1999, Monteris Medical is a privately held medical device company dedicated to the development of innovative MRI guided, laser-based cancer treatments. Monteris Medical markets the NeuroBlate System, a neurosurgical ablation system providing controlled therapy for difficult-to-treat brain tumors.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/07/12 | $9,000,000 |
Business Development Bank of Canada SWMF Life Science Fund | undisclosed | |
| 01/07/13 | $7,800,000 |
Business Development Bank of Canada SWMF Life Science Fund | undisclosed | |
| 10/22/13 | $13,000,000 | Venture Debt & Equity |
BDC Venture Capital Oxford Finance | undisclosed |
| 11/14/14 | $30,000,000 |
BDC Venture Capital Birchview Capital Vertical Group | undisclosed | |
| 06/02/17 | $26,600,000 | Series C |
BDC Venture Capital Birchview Capital SightLine Partners  Versant Ventures | undisclosed |
